Legislative Session number- 85

Bill Name: SF0651

5E Relating to health; modifying the patient's bill of rights to allow maternity
care patients in a maternity care facility to receive continuous support from
the doula of her choice and to be fully informed under certain conditions of
evidence based nonpharmacological pain relief methods; prohibiting the
manufacture, process or distribution in commerce of certain products containing
commercial decabromodiphenyl ethers, exemptions; providing application process
for exemptions and specifying certain exemption application fee requirements;
authorizing the commissioner to participate in regional or national multistate
clearinghouses to assist in certain duties; prohibiting phthalates in products
for young children; prohibiting manufacturers from replacing phthalates with
known human carcinogens; authorizing the pollution control agency (PCA) to
participate in the establishment and implementation of a multistate
clearinghouse to identify children's products containing phthalates and to
evaluate safer alternatives; requiring the commissioner of the pollution control
agency (PCA) to report to the legislature by a certain date on specific flame
retardant alternatives available for decabromodiphenyl ether and to convene a
fires safety committee to identify and evaluate the safety and effectiveness of
alternatives prior to phasing out decabromodiphenyl ether; appropriating money
to the commissioner of the PCA
(Ch. 301, 2008 - VETO)